By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences and Digilab have struck an agreement to co-market and sell their product lines together worldwide and to pursue joint research and development projects, Digilab said today.

The companies plan to co-market their respective technologies through industry publications, at scientific meetings, through their websites, at trade shows, and through common collaborator studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.